EMEA-003037-PIP01-21
Key facts
| Active substance |
Perflubutane
|
| Therapeutic area |
|
| Decision number |
P/0435/2021
|
| PIP number |
EMEA-003037-PIP01-21
|
| Pharmaceutical form(s) |
Powder and solvent for dispersion for injection
|
| Condition(s) / indication(s) |
Diagnostic evaluation of focal hepatic lesions
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
GE Healthcare AS
Tel.: +1494 544000 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|